Report Template Library

Abbreviated Clinical Study Report (ICH E3) as data

ICH E3 has been unrevised since 1995 and no machine-readable model of it existed publicly; ICH M11 did this for protocols in November 2025. library/templates/e3-abbreviated/sections.yaml encodes this document's 75-entry skeleton — number, title, slug and content model. assembly.yaml says what this report puts in it. Display numbers appear in neither: the assembler derives them from assembly order, so reordering the report is a one-line diff and a display's identity never changes (design D6). The library is plural — the same two files describe every document open.csr assembles.

75sections modelledthe whole skeleton, filled or not
17populated in this demoevery other section renders as a marked gap
6displays numberedassigned at assembly, not authored
14assembly slots configuredtext blocks and in-text displays

Section 16.1.9 is generated, not written: package versions, ARD hashes, data manifests and session info are emitted mechanically. E3 reserved that slot in 1995 and open.csr fills it from the build.

Assigned numbering

Derived from assembly.yaml post_text order at build time. The slug is what the specs, the ARDs and the bindings all refer to — reorder the report and every number here moves while no spec, ARD or sentence changes at all.

NumberDisplaySlugSection
Table 14.1.1Subject Dispositiont-disposition14.1
Table 14.1.2Demographic and Baseline Characteristicst-demographics14.1
Table 14.3.1.1Extent of Exposure to Study Drugt-exposure14.3.1
Table 14.3.1.2Overview of Treatment-Emergent Adverse Eventst-ae-overview14.3.1
Table 14.3.1.3Treatment-Emergent Adverse Events by System Organ Class and Preferred Termt-ae-common14.3.1
Listing 14.3.2.1Listing of Serious Adverse Eventsl-ae-serious14.3.2

The document skeleton

All 75 modelled sections, and what this report puts in each. Sections marked not in this demo still assemble, as headings that say so — the skeleton stays visible rather than being trimmed to what happens to be built.

§TitleContent modelTextDisplaysState
1Title Pagetextnot in this demo
2Synopsistextnot in this demo
3Table of Contents for the Individual Clinical Study Reportnot in this demo
4List of Abbreviations and Definition of Termstextnot in this demo
5Ethicsnot in this demo
5.1Independent Ethics Committee (IEC) or Institutional Review Board (IRB)textnot in this demo
5.2Ethical Conduct of the StudytextTXT-E3-0502populated
5.3Patient Information and ConsenttextTXT-E3-0503populated
6Investigators and Study Administrative Structuretextnot in this demo
7Introductiontextnot in this demo
8Study Objectivestextnot in this demo
9Investigational Plannot in this demo
9.1Overall Study Design and Plan: Descriptiontext in text displayTXT-E3-0901populated
9.3Selection of Study Populationnot in this demo
9.3.1Inclusion Criteriatextnot in this demo
9.3.2Exclusion Criteriatextnot in this demo
9.3.3Removal of Patients from Therapy or Assessmenttextnot in this demo
9.4Treatmentsnot in this demo
9.4.1Treatments Administeredtextnot in this demo
9.4.2Identity of Investigational Product(s)textnot in this demo
9.4.3Method of Assigning Patients to Treatment Groupstextnot in this demo
9.4.4Selection of Doses in the Studytextnot in this demo
9.4.5Selection and Timing of Dose for Each Patienttextnot in this demo
9.4.6Blindingtextnot in this demo
9.4.7Prior and Concomitant Therapytext in text displaynot in this demo
9.4.8Treatment Compliancetext in text displaynot in this demo
9.5Efficacy and Safety Variablesnot in this demo
9.5.1Efficacy and Safety Measurements Assessed and Flow Charttext in text displaynot in this demo
9.6Data Quality Assurancetextnot in this demo
9.7Statistical Methods Planned in the Protocol and Determination of Sample Sizenot in this demo
9.7.1Statistical and Analytical Planstextnot in this demo
9.7.2Determination of Sample Sizetextnot in this demo
9.8Changes in the Conduct of the Study or Planned AnalysestextTXT-E3-0908populated
10Study Patientsnot in this demo
10.1Disposition of Patientstext in text displayTXT-E3-1001 TXT-E3-1002Table 14.1.1populated
10.2Protocol Deviationstext in text displaynot in this demo
11Efficacy Evaluationnot in this demo
11.1Data Sets Analysedtext in text displayTXT-E3-1101populated
11.2Demographic and Other Baseline Characteristicstext in text displayTXT-E3-1102Table 14.1.2populated
11.3Measurements of Treatment Compliancetext in text displaynot in this demo
12Safety Evaluationnot in this demo
12.1Extent of Exposuretext in text displayTXT-E3-1201Table 14.3.1.1populated
12.2Adverse Events (AEs)not in this demo
12.2.1Brief Summary of Adverse Eventstext in text displayTXT-E3-1221Table 14.3.1.2populated
12.2.2Display of Adverse Eventstext in text displayTXT-E3-1222Table 14.3.1.3populated
12.2.3Analysis of Adverse Eventstext in text displaynot in this demo
12.2.4Listing of Adverse Events by PatienttextTXT-E3-1224populated
12.3Deaths, Other Serious Adverse Events, and Other Significant Adverse Eventsnot in this demo
12.3.1Listing of Deaths, Other Serious Adverse Events and Other Significant Adverse Eventstext in text displayTXT-E3-1231Listing 14.3.2.1populated
12.3.1.1Deathstextnot in this demo
12.3.1.2Other Serious Adverse Eventstextnot in this demo
12.3.1.3Other Significant Adverse Eventstextnot in this demo
12.3.2Narratives of Deaths, Other Serious and Certain Other Significant Adverse Eventstextnot in this demo
12.3.3Analysis and Discussion of Deaths, Other Serious and Other Significant Adverse Eventstextnot in this demo
12.6Safety ConclusionstextTXT-E3-1206populated
13Discussion and Overall ConclusionstextTXT-E3-1300populated
14Tables, Figures and Graphs Referred to but not Included in the Textpost text indexnot in this demo
14.1Demographic Datapost text indexTable 14.1.1 Table 14.1.2populated
14.2Efficacy Datapost text indexnot in this demo
14.3Safety Datanot in this demo
14.3.1Displays of Adverse Eventspost text indexTable 14.3.1.1 Table 14.3.1.2 Table 14.3.1.3populated
14.3.2Listings of Deaths, Other Serious and Significant Adverse Eventspost text indexListing 14.3.2.1populated
14.3.3Narratives of Deaths, Other Serious and Certain Other Significant Adverse Eventstextnot in this demo
15Reference Listtextnot in this demo
16Appendicesnot in this demo
16.1Study Informationnot in this demo
16.1.1Protocol and Protocol Amendmentstextnot in this demo
16.1.3List of IEC or IRB and Representative Written Information for Patient and Sample Consent Formstextnot in this demo
16.1.7Randomisation Scheme and Codes (patient identification and treatment assigned)textnot in this demo
16.1.9Documentation of Statistical Methodstext generated provenancenot in this demo
16.2Patient Data Listingsnot in this demo
16.2.1Discontinued Patientspost text indexnot in this demo
16.2.3Patients Excluded from the Efficacy Analysispost text indexnot in this demo
16.2.4Demographic Datapost text indexnot in this demo
16.2.7Adverse Event Listings (each patient)post text indexnot in this demo